| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $690K | +10.4% | +43.2% |
| Cost of Revenue | $257K | +19.0% | +53.9% |
| Gross Profit | $433K | +5.9% | +37.5% |
| R&D Expense | $400K | -6.3% | -11.3% |
| SG&A Expense | $1.4M | -13.5% | -2.2% |
| Operating Income | -$1.3M | +16.5% | +12.9% |
| Interest Expense | $6K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.3M | +20.2% | +189.0% |
| Short-term Investments | $3.0M | — | — |
| Accounts Receivable | $454K | -3.4% | +112.1% |
| Inventory | $767K | +7.9% | -12.8% |
| Current Assets | $11.8M | +57.6% | +196.6% |
| Total Assets | $14.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.1M | — | — |
| Capital Expenditures | $125K | — | — |
| Investing Cash Flow | -$3.1M | — | — |
| Financing Cash Flow | $13.1M | — | — |
| Free Cash Flow | -$4.2M | — | — |
| +0.0% |
| +0.0% |
| Net Income | -$1.3M | +19.7% | +14.2% |
| EPS (Basic) | -$0.28 | +67.8% | +86.5% |
| EPS (Diluted) | -$0.28 | +67.8% | +86.5% |
| +41.1% |
| +228.7% |
| Current Liabilities | $748K | -7.7% | +19.1% |
| Total Liabilities | $3.3M | -3.3% | +310.5% |
| Stockholders' Equity | $11.3M | +62.6% | +210.8% |